(Q36655604)

15 August 2017

1 reference

title

Antiepileptic drugs in development (English)

1 reference

15 August 2017

Jacqueline French

2

0 references

author name string

John R Pollard

series ordinal

1

1 reference

15 August 2017

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

5

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

1064-1067

1 reference

The neurobiology of antiepileptic drugs

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Diverse mechanisms of antiepileptic drugs in the development pipeline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

M-current modulators alter rat spinal nociceptive transmission: an electrophysiological study in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Retigabine: in partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Rufinamide: CGP 33101, E 2080, RUF 331, Xilep

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

A crossover, add-on trial of talampanel in patients with refractory partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Non-competitive AMPA antagonists of 2,3-benzodiazepine type

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

Potential new methods for antiepileptic drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970627-5

7 January 2021

10.1016/S1474-4422(06)70627-5

Identifiers

DOI

1 reference

15 August 2017

1 reference